Pfizer (PFE)
$28.05
0.00 (0.00%)
PFE Stock Quote Delayed 30 Minutes
Acadia Pharmaceuticals Inc. (ACAD) Flirts With a Pfizer Inc. (PFE) Buyout
Acadia stock took a big leap on rumors that Pfizer (PFE) is interested in a buyout. But ACAD stock investors shouldn't get too excited yet.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
157.27B
PE Ratio
-561.00
EPS
-0.05
Volume (Avg. Vol.)
16,739
Day's Range
-
52-Week Range
$25.20 - $37.80
Dividend & Yield
$1.64 (5.85%)
PFE Stock Predictions, Articles, and Pfizer News
Value Battle: Pfizer Inc. (PFE) vs. Merck & Co., Inc. (MRK)
Pfizer (PFE) hasn't done very well in 2016, making its value battle with Merck (MRK) an interesting proposition.
Eli Lilly and Co (LLY) Drug Failure Doesn’t Answer the Bigger Question
Eli Lilly (LLY) may be a bargain after today's plunge, but LLY stock won't be a good Alzheimer's bet anytime in the foreseeable future.
Cloud M&A: Oracle Corporation (ORCL) to Buy DNS Provider Dyn
Oracle Corporation (ORCL) is planning to purchase DNS provider Dyn in an effort to reduce load times and speed up service for its customers.
17 Pharmaceuticals Stocks to Sell Now
This week, the ratings of 17 Pharmaceuticals stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
26 Pharmaceuticals Stocks to Sell Now
The ratings of 26 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Thursday’s Vital Data: Bank of America Corp (BAC), Apple Inc. (AAPL) and Pfizer Inc. (PFE)
Bank of America (BAC) a winner Apple (AAPL) a loser in Trump bump rally and Pfizer (PFE) may be exiting consumer health.
The Dow Jones Posts Massive Trump Rebound
In the end, the Dow Jones gained 1.4% after flirting with a new record high, the S&P 500 gained 1.1%, the Nasdaq gained 1.1% and the Russell gained 3.1%.
Dow Jones Tests 18,000 as Pfizer, Apple Inc. Take a Hit
In the end, the Dow lost 0.6%, the S&P 500 lost 0.7%, the Nasdaq dropped 0.7% and the Russell 2000 ended lower by 1.1%.
PFE Stock: Ignore Pfizer Inc.’s Earnings Miss at Your Own Peril
Pfizer missed on earnings, and PFE stock slipped as a result. But even if you don't own Pfizer, you don't want to ignore what's happening there.
These 3 Dividend Stocks Are the Place To Be Today
In a suppressed rate environment, dividend-paying stocks will continue to lead the way, and these 3 dividend stocks are sure winners
Tesaro Inc (TSRO) Soars on Trial Data, Analyst Upgrades
Tesaro Inc (NASDAQ:TSRO) is up 18% after posting positive data in its Nova trial for treating ovarian cancer. Analysts are beside themselves.
